Case 4 - Lung cancer and pleural effusion Flashcards
How common of a cancer is lung cancer?
- Biggest cause of cancer related deaths worldwide and UK
5 year survival rate lung cancer
16%
What are most lung cancers caused by in UK?
76% is from smoking
Lung cancer presentation features
- Asymptomatic - incidental finding
- Respiratory symptoms/deterioration
- SVC obstruction - tortuous veins on chest and distended veins in upper limbs and head/neck
- Horners syndrome
- Mets disease - liver, adrenals (addisons), bone, pleural, CNS
- Paraneoplastic - hypercalcaemia (PTHrp), SIADH, Cushings (ACTH), Lambert Eaton mysathenic syndrome
- Increased risk of thrombo-embolic disease
Horners syndrome
- Miosis - small pupil
- Anhidrosis
- Ptosis
Caused often by Pancoast apical lung cancer compressing sympathetic chain - interupted
Risk factors for lung cancer
- Large number of smoking pack years
- Airflow obstruction
- Increasing age
- FH of lung cancer
- Exposure to other carcinogens eg asbestos
What is performance status?
WHO scale - is used to assess fitness of patient and how likely they are to cope with certain treatments and disease
Perfomance status stages
- Normal - fully active with no restriction
- Restricted in physical strenuous activity but ok with light work
- Ambulatory and able to self care but unable to carry out work activities, up and about >50% waking hours
- Capable of limited sellf care, confined to bed or chair >50% waking hours
- Completely disabled
- Dead
Blood diagnostic tests for lung cancer
- FBC
- U&E
- Calcium
- LFTs
- INR
Imaging for lung cancer
- CXR
- Staging CT - spinal CT thorax and upper abdo - for TNM staging
- PET scan - MDT decision if patient is surgical candidate and CT suggests low stage, helps detect small mets not seen in staging CT
Histology options for biopsying lung cancer
- US guided neck node for cytology via fine needle aspiration if lymphadenopathy
- Bronchoscopy - endobronchial, transbronchial, endobronchial US (if mediastinal lymphadenopathy)
- CT biopsy
- Thoracoscopy if pleural effusion present
Histological classification of lung cancer
- Small cell lung cancer (SLCL, oat cell)
- Non-small cell lung cancer (NSCLC)
Examples of non-small cell lung cancer
- Squamous cell
- Adenocarcinoma
- Large cell carcinoma
- Bronchoalveolar cancer
Lung cancer treatment options
- Curative surgery - for stages I and II - if fit
- Surgery and adjuvant chemotherapy for stage IIIa
- Chemotherapy - stage III/IV and PS0-2
- Radiotherapy - curative if not fit for surgery or palliative
- Palliative care
- Do nothing - watch and wait
What is curative radiotherapy?
CHART - continious hyperfractionated accelerated radiotherapy
NSCLC survival rates at 5 years
- All - 15-23%
- I - 65-80%
- II - 50-60%
(these are both following surgical resection) - III - 20%
- IV - 1-5%
Treatment for SCLC
- Rapid growth rate and almost always too extensive for surgery
- Chemotherapy = main treatment
- Palliative radiotherapy too
Prognosis for SCLC
- Untreated - median survival 8-16 weeks
- Combo chemotherapy median survival is 7-15 months